Free Trial

Tilray (TLRY) Competitors

Tilray logo
$1.35 -0.03 (-2.17%)
(As of 11/15/2024 ET)

TLRY vs. CRON, USNA, MNMD, CDXC, CGC, BTMD, ACB, FOMX, MDWD, and FTLF

Should you be buying Tilray stock or one of its competitors? The main competitors of Tilray include Cronos Group (CRON), USANA Health Sciences (USNA), Mind Medicine (MindMed) (MNMD), ChromaDex (CDXC), Canopy Growth (CGC), biote (BTMD), Aurora Cannabis (ACB), Menlo Therapeutics (FOMX), MediWound (MDWD), and FitLife Brands (FTLF).

Tilray vs.

Tilray (NASDAQ:TLRY) and Cronos Group (NASDAQ:CRON) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, community ranking, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and valuation.

Tilray currently has a consensus target price of $2.63, indicating a potential upside of 94.44%. Cronos Group has a consensus target price of $3.00, indicating a potential upside of 49.25%. Given Tilray's stronger consensus rating and higher possible upside, research analysts plainly believe Tilray is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25
Cronos Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Cronos Group received 17 more outperform votes than Tilray when rated by MarketBeat users. Likewise, 61.13% of users gave Cronos Group an outperform vote while only 59.21% of users gave Tilray an outperform vote.

CompanyUnderperformOutperform
TilrayOutperform Votes
447
59.21%
Underperform Votes
308
40.79%
Cronos GroupOutperform Votes
464
61.13%
Underperform Votes
295
38.87%

Tilray has a beta of 2.14, suggesting that its share price is 114% more volatile than the S&P 500. Comparatively, Cronos Group has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500.

Cronos Group has lower revenue, but higher earnings than Tilray. Cronos Group is trading at a lower price-to-earnings ratio than Tilray, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray$788.94M1.55-$244.98M-$0.27-5.00
Cronos Group$87.24M8.81-$73.96M-$0.13-15.46

9.4% of Tilray shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 0.9% of Tilray shares are held by company insiders. Comparatively, 6.9% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Cronos Group had 1 more articles in the media than Tilray. MarketBeat recorded 17 mentions for Cronos Group and 16 mentions for Tilray. Tilray's average media sentiment score of 0.32 beat Cronos Group's score of 0.29 indicating that Tilray is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tilray
3 Very Positive mention(s)
4 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cronos Group
4 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Tilray has a net margin of -26.79% compared to Cronos Group's net margin of -42.65%. Tilray's return on equity of -2.00% beat Cronos Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray-26.79% -2.00% -1.60%
Cronos Group -42.65%-2.56%-2.47%

Summary

Tilray beats Cronos Group on 11 of the 18 factors compared between the two stocks.

Get Tilray News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLRY vs. The Competition

MetricTilrayMedicinals & botanicals IndustryStaples SectorNASDAQ Exchange
Market Cap$1.22B$1.26B$14.91B$8.66B
Dividend YieldN/AN/A2.67%4.06%
P/E Ratio-5.0045.4223.6817.45
Price / Sales1.557.383.5269.07
Price / CashN/A12.9221.1036.36
Price / Book0.331.945.955.87
Net Income-$244.98M-$52.95M$582.17M$225.66M
7 Day Performance-9.40%-2.37%-0.67%-1.34%
1 Month Performance-14.01%-2.50%-2.71%1.15%
1 Year Performance-26.23%7.07%10.46%24.02%

Tilray Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLRY
Tilray
2.0085 of 5 stars
$1.35
-2.2%
$2.63
+94.4%
-22.9%$1.22B$788.94M-5.002,650Options Volume
CRON
Cronos Group
1.8769 of 5 stars
$2.17
-4.0%
N/A+7.5%$829.59M$87.24M-16.69356Short Interest ↓
Analyst Revision
News Coverage
USNA
USANA Health Sciences
2.8527 of 5 stars
$40.91
+1.0%
N/A-11.8%$779.75M$921.01M14.461,800
MNMD
Mind Medicine (MindMed)
2.7154 of 5 stars
$8.40
+2.6%
N/A+215.4%$605.62MN/A-3.7157Options Volume
News Coverage
Gap Up
CDXC
ChromaDex
4.3851 of 5 stars
$7.01
-3.3%
N/A+367.1%$535.42M$83.57M701.70106Short Interest ↓
Gap Down
High Trading Volume
CGC
Canopy Growth
1.6253 of 5 stars
$3.94
flat
N/A-29.7%$369.81M$220.27M-0.801,029Short Interest ↓
Analyst Revision
BTMD
biote
3.4008 of 5 stars
$6.72
+21.7%
N/A+11.1%$364.36M$185.36M25.85194Short Interest ↓
Analyst Revision
News Coverage
High Trading Volume
ACB
Aurora Cannabis
0.6614 of 5 stars
$4.54
-4.0%
N/A-9.7%$248.99M$296.99M-5.971,073Short Interest ↑
News Coverage
FOMX
Menlo Therapeutics
N/A$2.99
flat
N/AN/A$184.12M$3.60M-2.3080
MDWD
MediWound
2.0214 of 5 stars
$16.60
-1.8%
N/A+93.2%$179.11M$18.69M-7.6980Upcoming Earnings
Positive News
FTLF
FitLife Brands
4.3562 of 5 stars
$34.88
+3.3%
N/A+52.6%$160.45M$52.70M21.6620Short Interest ↓
Analyst Revision
News Coverage
High Trading Volume

Related Companies and Tools


This page (NASDAQ:TLRY) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners